Valuation: IRIDEX Corporation

Market Cap 19.67M 17.19M 15.8M 14.73M 27.94M 1.87B 28.36M 190M 73.75M 921M 73.83M 72.25M 3.17B P/E 2026 *
-22.6x
P/E 2027 * 56.5x
Enterprise Value 19.67M 17.19M 15.8M 14.73M 27.94M 1.87B 28.36M 190M 73.75M 921M 73.83M 72.25M 3.17B EV / Sales 2026 *
0.37x
EV / Sales 2027 * 0.35x
Free-Float
71.14%
Yield 2026 *
-
Yield 2027 * -
1 day-3.42%
Current month-1.31%
1 month-1.74%
3 months+15.27%
6 months-3.42%
Current year-0.88%
1 week 1.12
Extreme 1.12
1.19
1 month 1.09
Extreme 1.09
1.2
Current year 0.95
Extreme 0.9496
1.65
1 year 0.87
Extreme 0.8688
1.65
3 years 0.78
Extreme 0.782
3.65
5 years 0.78
Extreme 0.782
9.46
10 years 0.78
Extreme 0.782
16.64
Manager TitleAgeSince
Chief Executive Officer 54 2024-09-30
Director of Finance/CFO 68 2018-12-17
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 66 2022-03-16
Chairman 77 2010-08-31
Chairman 60 2020-06-23
Date Insider Type Main position Quantity % Market Cap.
Jun. 12Tax

Chief Executive Officer

-3,990 0.0229%
Jun. 12Tax

Chief Financial Officer

-2,691 0.0155%
Jun. 11Buy

Chief Financial Officer

975 0.0056%
Change 5-day change 1-year change 3-year change Capi.($)
-3.42%0.00%+21.51%-47.20% 19.67M
+1.97%+2.03%+21.92%+0.83% 195B
+5.87%+5.27%-21.76%+26.78% 151B
+2.17%+0.89%-2.59%-16.42% 140B
+4.83%+2.06%-56.73%-15.69% 67.09B
+2.59%+3.95%+22.89%+3.15% 54.34B
+0.03%+2.19%-25.48%-31.00% 44.63B
+0.31%+1.30%+8.30%+43.25% 37.24B
-2.02%-3.91%+7.67%+9.53% 36.91B
+4.24%+4.66%-18.42%-2.34% 30.24B
Average +1.66%+2.04%-4.27%-2.91% 75.6B
Weighted average by Cap. +2.78%+3.44%-4.03%+2.02%

Financials

2026 *2027 *
Net sales 53M 46.33M 42.58M 39.69M 75.28M 5.05B 76.42M 511M 199M 2.48B 199M 195M 8.55B 56.77M 49.62M 45.61M 42.51M 80.63M 5.4B 81.85M 547M 213M 2.66B 213M 209M 9.16B
Net income -795K -695K -639K -595K -1.13M -75.7M -1.15M -7.67M -2.98M -37.21M -2.98M -2.92M -128M 361K 316K 290K 270K 513K 34.37M 521K 3.48M 1.35M 16.9M 1.36M 1.33M 58.22M
Net Debt - -
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
26-07-02 $1.130 -3.42% 27,467
26-07-01 $1.170 +2.18% 9,856
26-06-30 $1.145 +0.88% 23,577
26-06-29 $1.135 +0.44% 57,032
26-06-26 $1.130 -4.24% 29,320
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.130USD
Average target price
2.750USD
Spread / Average Target
+143.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRIX Stock